Tyra Biosciences (TYRA) Interest Coverage Ratio (2020 - 2023)
Tyra Biosciences' (TYRA) quarterly Interest Coverage Ratio came in at 0.13 in Q1 2026, up 94.53% YoY from 0.07 in Q1 2025, and up 99.93% on a QoQ basis from 182.58 in Q4 2025.
Analysis
Tyra Biosciences (TYRA) Interest Coverage Ratio (2020 - 2023) Analysis & Trends
Tyra Biosciences (TYRA) has 7 years of Interest Coverage Ratio data on file, last reported at 0.13 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 94.53% year-over-year to 0.13 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.44 (up 94.78% YoY) and the FY2025 annual result came in at 0.71, up 76.93% from the prior year.
- Interest Coverage Ratio advanced to 0.13 in Q1 2026, from 182.58 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 100.12 in Q4 2022 to a low of 182.58 in Q4 2025.
- A 5-year average of 12.72 and a median of 0.6 in 2023 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio jumped 98.23% — and 2025, when it plunged 502.29%.
- Tracing TYRA's Interest Coverage Ratio over 5 years: stood at 100.12 in 2022, then tumbled by 100.6% to 0.6 in 2023, then sank by 16440.86% to 99.15 in 2024, then tumbled by 84.15% to 182.58 in 2025, then soared by 99.93% to 0.13 in 2026.
- The last three Interest Coverage Ratio figures came in at 0.13 (Q1 2026), 182.58 (Q4 2025), and 0.72 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Tyra Biosciences | 1.94 Bn | 1.94 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -762.57 |
| Mar 31, 2023 | -14,334.00 |
| Dec 31, 2022 | -455.09 |
| Sep 30, 2022 | -2,729.00 |
| Jun 30, 2022 | -1,186.77 |
| Mar 31, 2022 | -1,483.40 |
| Dec 31, 2021 | -3,310.67 |
| Sep 30, 2021 | -948.29 |
| Jun 30, 2021 | -688.50 |
| Dec 31, 2020 | -612.83 |
| Sep 30, 2020 | -333.14 |